Ascentage Pharma Group International (AAPG) Diversifiers

Equity · Currency in USD · Last updated Jun 4, 2026

Ascentage Pharma Group International is a clinical-stage biotechnology company developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases, with a focus on targeted inhibitors such as HQP1351 for BCR-ABL1 mutants and a pipeline including oral inhibitors for hematologic malignancies, solid tumors, and advanced solid tumors. The company also engages in medical research, clinical development, and collaborations with biotechnology, pharmaceutical companies, and research institutions.

Looking to balance out your exposure to AAPG? The ETFs below have the lowest correlation with AAPG — they tend to move on their own, which can help reduce risk when AAPG drops. The stock ideas table highlights individual companies that behave independently from AAPG.

No Diversifiers Found for AAPG

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements AAPG

Add AAPG to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with AAPG